amvuttra(VUTRISIRAN)Medication DetailsAlnylam Pharmaceuticals, Inc.Usage: AMVUTTRA is indicated for treating the polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adults.Medication Details
onpattro(patisiran)Medication DetailsAlnylam Pharmaceuticals, Inc.Usage: ONPATTRO is indicated for treating the polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adults.Medication Details
tegsedi(inotersen)Medication DetailsAkcea Therapeutics, Inc.Usage: TEGSEDI is indicated for treating the polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adults.Medication DetailsDrug Interactions